Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study

✍ Scribed by Hagop Kantarjian; Deborah Thomas; Jeffrey Jorgensen; Elias Jabbour; Partow Kebriaei; Michael Rytting; Sergernne York; Farhad Ravandi; Monica Kwari; Stefan Faderl; Mary Beth Rios; Jorge Cortes; Luis Fayad; Robert Tarnai; Sa A Wang; Richard Champlin; Anjali Advani; Susan O'Brien

• Book ID: 117785905
• Publisher: The Lancet
• Year: 2012
• Tongue: English
• Weight: 255 KB
• Volume: 13
• Category: Article
• ISSN: 1470-2045
• DOI: 10.1016/s1470-2045(11)70386-2